α1アンチトリプシン欠乏症(Alpha- Antitrypsin Deficiency):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2548CTIDB
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月31日
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、世界におけるα1アンチトリプシン欠乏症(Alpha- Antitrypsin Deficiency) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - α1アンチトリプシン欠乏症(Alpha- Antitrypsin Deficiency)
  - 当レポートの概要
・α1アンチトリプシン欠乏症(Alpha- Antitrypsin Deficiency):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015″ provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha- Antitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Alpha- Antitrypsin Deficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Alpha- Antitrypsin Deficiency 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials 25
Prominent Drugs 26
Latest Clinical Trials News on Alpha- Antitrypsin Deficiency 27
Jan 07, 2015: Kamada Reports Encouraging Discussions with European Co-Rapporteurs Regarding European Filing for Inhaled Alpha-1 Antitrypsin to Treat AATD 27
Nov 18, 2014: Arrowhead Files For Regulatory Permission To Begin Phase 1 Trial Of RNAi Therapeutic ARC-AAT 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Grifols, S.A. 28
Clinical Trial Overview of Grifols, S.A. 28
Baxter International Inc. 29
Clinical Trial Overview of Baxter International Inc. 29
Kamada Ltd. 30
Clinical Trial Overview of Kamada Ltd. 30
CSL Limited 31
Clinical Trial Overview of CSL Limited 31
Applied Genetic Technologies Corporation 32
Clinical Trial Overview of Applied Genetic Technologies Corporation 32
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
Arrowhead Research Corporation 35
Clinical Trial Overview of Arrowhead Research Corporation 35
Clinical Trial Overview of Top Institutes / Government 36
Hospices Civils de Lyon 36
Clinical Trial Overview of Hospices Civils de Lyon 36
University of Pittsburgh 37
Clinical Trial Overview of University of Pittsburgh 37
University of Massachusetts Worcester Campus 38
Clinical Trial Overview of University of Massachusetts Worcester Campus 38
Alpha-1 Foundation 39
Clinical Trial Overview of Alpha-1 Foundation 39
University of Massachusetts 40
Clinical Trial Overview of University of Massachusetts 40
Weill Cornell Medical College 41
Clinical Trial Overview of Weill Cornell Medical College 41
University of Miami 42
Clinical Trial Overview of University of Miami 42
University of Florida 43
Clinical Trial Overview of University of Florida 43
Five Key Clinical Profiles 44
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79

List of Tables
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 16
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 17
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Alpha- Antitrypsin Deficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2015* 28
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 29
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Kamada Ltd., 2015* 30
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2015* 31
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Applied Genetic Technologies Corporation, 2015* 32
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 33
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Arrowhead Research Corporation, 2015* 35
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2015* 36
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015* 37
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts Worcester Campus, 2015* 38
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Alpha-1 Foundation, 2015* 39
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2015* 40
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 41
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2015* 42
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 43

List of Figures
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 16
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 78

【レポートのキーワード】

α1アンチトリプシン欠乏症(Alpha- Antitrypsin Deficiency)、治験、臨床試験、治験、治療薬

★調査レポート[α1アンチトリプシン欠乏症(Alpha- Antitrypsin Deficiency):世界の治験レビュー(2015年上半期版)] (コード:GDHC2548CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[α1アンチトリプシン欠乏症(Alpha- Antitrypsin Deficiency):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆